Info

🌱來自: castleman_disease

Classification

• CD: Castleman disease;
• POEMS: Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal plasma cell disorder, Skin changes
• TAFRO: Thrombocytopenia, Ascites(or Anasarca), reticulin Fibrosis(or Fever), Renal dysfunction, and Organomegaly
• NOS: not otherwise specified

FDC: Follicular dendritic cell

Siblings

• A 41-Year-Old Man with Dyspnea, Fever, and Lymphadenopathy
• CT of the Chest, Abdomen, and Pelvis
• Histopathological Presentation
• Bone marrow examination
• Diagnosis
• Definition
• Epidemiology
• Pathogenesis
• Pahtogenesis (continued)
• Histopathological of Castleman Disease
• Histopathological of Castleman Disease (continued)
• Follicles With Mantle Zones With An “Onion Skin” Pattern
• Hyaline vascular Castleman disease
• Grading of pathologic features seen in iMCD
• Algorithmic approach for assessment of lymph node with features of CD
• Diagnostic criteria for iMCD
• Significant clinical, histologic, and immunologic overlap
• Conditions Characterized by Inflammation and Differential Diagnosis for iMCD
• Diagnostic criteria for iMCD-TAFRO
• Severity scoring of iMCD
• The management of UCD
• Management of iMCD
• IL-6 pathway
• IL-6 Inhibitors
• Siltuximab for multicentric Castleman’s disease
• Definitions of Treatment Response
• Which type of biopsy would you use in order to prevent the delay of a Castleman disease diagnosis?
• According to guidelines, which type of therapy is most optimal for your patient with idiopathic multicentric Castleman disease?
• What is required for the diagnosis of iMCD?
• Which of the following is true regarding the diagnosis of iMCD?
• Take home message
• [[thank_you_for_
  your_time_and_attention.md|Thank you for
  your time and attention]]
• Table of Contents